Phibro Animal Health Corporation (PAHC)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
MEDIUM DILUTION RISKDilution score: 31/100 (MEDIUM), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 5.47% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
- Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings?
- PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
- Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
- Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
- Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?
- PAHC or LMAT: Which Is the Better Value Stock Right Now?
- Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Increased dietary calcium inclusion in fully acidified prepartum diets improved postpartum uterine health and fertility when fed to Holstein cows. — Theriogenology 2020 Jan 15 PMID 31711709
- Effects of an immunomodulatory feed additive on intramammary infection prevalence and somatic cell counts in a dairy herd experiencing major health issues. — Res Vet Sci 2019 Jun PMID 30909121
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Phibro Animal Health Corporation.
Full PAHC Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.